Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.

Neves FS, Ferreira RM, Pereira IA, Zimmermann AF, Lin K.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):133-40. Epub 2013 May 28. Review.

PMID:
23739034
2.

A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.

Watanabe S, Aizawa-Yashiro T, Tsuruga K, Kinjo M, Ito E, Tanaka H.

Rheumatol Int. 2013 Dec;33(12):3105-8. doi: 10.1007/s00296-012-2628-5. Epub 2012 Dec 25. Review.

PMID:
23266507
3.

Switching of anti-TNF-α agents in Behçet's disease.

Furuta S, Chow YW, Chaudhry AN, Jayne D.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S62-8. Epub 2012 Sep 27.

PMID:
23010387
4.

TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.

Hatemi I, Hatemi G, Pamuk ON, Erzin Y, Celik AF.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S129-37. Epub 2015 Oct 20. Review.

PMID:
26486925
5.

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.

Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D; French Behçet Network.

J Autoimmun. 2015 Aug;62:67-74. doi: 10.1016/j.jaut.2015.06.005. Epub 2015 Jul 8.

PMID:
26162757
6.

Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease.

Melillo N, Sangle S, Stanford MR, Andrews TC, D'Cruz DP.

Clin Rheumatol. 2007 Aug;26(8):1365-7. Epub 2006 Oct 25.

PMID:
17063282
7.

Whole thoracal spinal cord involvement in case of neuro-Behçet's disease.

Kabukçu T, Edemci S, Uçan H, Celik C, Gunes HN, Yoldas T.

Rheumatol Int. 2009 Apr;29(6):707-9. doi: 10.1007/s00296-008-0752-z. Epub 2008 Nov 4.

PMID:
18982328
8.
9.

Neuro-Behçet's disease mimicking a cranial tumour.

Senol S, Ucar M, İmamoğlu H, Yildirim A.

BMJ Case Rep. 2015 Jun 21;2015. pii: bcr2014208997. doi: 10.1136/bcr-2014-208997.

10.

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G.

Ann Rheum Dis. 2003 Mar;62(3):280-1. No abstract available.

11.

Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.

Chan E, Sangle SR, Coghlan JG, D'Cruz DD.

Autoimmun Rev. 2016 Apr;15(4):375-8. doi: 10.1016/j.autrev.2016.01.003. Epub 2016 Jan 8. Review.

PMID:
26777307
12.

A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.

Alty JE, Monaghan TM, Bamford JM.

Clin Neurol Neurosurg. 2007 Apr;109(3):279-81. Epub 2006 Dec 14.

PMID:
17174468
13.

Atypical presentation of Behçet's disease with central nervous system involvement successfully treated with infliximab.

Studer U, Ruehe B, Waldegg G, Vajtai I, Escher R, Aeberli D.

Rheumatol Int. 2012 May;32(5):1431-5. doi: 10.1007/s00296-011-1915-x. Epub 2011 Mar 29.

PMID:
21445544
14.

Refractory neuro-Behçet treated by tocilizumab: a case report.

Urbaniak P, Hasler P, Kretzschmar S.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S73-5. Epub 2012 Sep 27.

PMID:
23020826
15.

Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.

Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A.

Orphanet J Rare Dis. 2013 Jan 29;8:18. doi: 10.1186/1750-1172-8-18. Review.

16.

Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.

Yoon DL, Kim YJ, Koo BS, Kim YG, Lee CK, Yoo B.

Int J Rheum Dis. 2014 May;17(4):453-8. doi: 10.1111/1756-185X.12265. Epub 2014 Feb 8.

PMID:
24506839
17.

Neuro-Behçet's syndrome: differential diagnosis and management.

Diri E, Espinoza LR.

Curr Rheumatol Rep. 2006 Aug;8(4):317-22. Review.

PMID:
16839512
18.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Calvo-Río V, Blanco R, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Hernandez Garfella M, Valls Pascual E, Martínez-Costa L, Sellas-Fernández A, Cordero Coma M, Díaz-Llopis M, Gallego R, Salom D, García Serrano JL, Ortego N, Herreras JM, Fonollosa A, García-Aparicio AM, Maíz O, Blanco A, Torre I, Fernández-Espartero C, Jovani V, Peiteado-Lopez D, Pato E, Cruz J, Fernández-Cid C, Aurrecoechea E, García M, Caracuel MA, Montilla C, Atanes A, Hernandez FF, Insua S, González-Suárez S, Sánchez-Andrade A, Gamero F, Linares L, Romero-Bueno F, García AJ, Almodovar R, Minguez E, Carrasco Cubero C, Olive A, Vázquez J, Ruiz Moreno O, Jiménez-Zorzo F, Manero J, Muñoz Fernández S, Rueda-Gotor J, González-Gay MA.

Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.

PMID:
24996907
19.

Behçet's disease with cerebral vasculitis.

Scardamaglia L, Desmond PM, Gonzales MF, Bendrups A, Brodtmann A, Kay TW.

Intern Med J. 2001 Dec;31(9):560-1. No abstract available.

PMID:
11767874
20.

Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.

Delunardo F, Conti F, Margutti P, Alessandri C, Priori R, Siracusano A, Riganò R, Profumo E, Valesini G, Sorice M, Ortona E.

Arthritis Res Ther. 2006;8(3):R71. Epub 2006 Apr 12.

Supplemental Content

Support Center